Australia · Delayed Price · Currency is AUD NOVONIX Statistics
Total Valuation
NOVONIX has a market cap or net worth of AUD 109.74 million. The enterprise value is 155.68 million.
| Market Cap | 109.74M |
| Enterprise Value | 155.68M |
Important Dates
The next estimated earnings date is Monday, October 26, 2026.
| Earnings Date | Oct 26, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
NOVONIX has 997.61 million shares outstanding. The number of shares has increased by 41.30% in one year.
| Current Share Class | 997.61M |
| Shares Outstanding | 997.61M |
| Shares Change (YoY) | +41.30% |
| Shares Change (QoQ) | +17.70% |
| Owned by Insiders (%) | 3.79% |
| Owned by Institutions (%) | 24.51% |
| Float | 849.84M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 13.52 |
| PB Ratio | 0.48 |
| P/TBV Ratio | 0.52 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 19.17 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.97, with a Debt / Equity ratio of 0.58.
| Current Ratio | 0.97 |
| Quick Ratio | 0.88 |
| Debt / Equity | 0.58 |
| Debt / EBITDA | n/a |
| Debt / FCF | -1.17 |
| Interest Coverage | -3.89 |
Financial Efficiency
Return on equity (ROE) is -65.64% and return on invested capital (ROIC) is -14.00%.
| Return on Equity (ROE) | -65.64% |
| Return on Assets (ROA) | -12.90% |
| Return on Invested Capital (ROIC) | -14.00% |
| Return on Capital Employed (ROCE) | -27.56% |
| Weighted Average Cost of Capital (WACC) | 10.36% |
| Revenue Per Employee | 42,289 |
| Profits Per Employee | -731,962 |
| Employee Count | 192 |
| Asset Turnover | 0.02 |
| Inventory Turnover | 2.84 |
Taxes
In the past 12 months, NOVONIX has paid 36,921 in taxes.
| Income Tax | 36,921 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -75.28% in the last 52 weeks. The beta is 0.85, so NOVONIX's price volatility has been lower than the market average.
| Beta (5Y) | 0.85 |
| 52-Week Price Change | -75.28% |
| 50-Day Moving Average | 0.13 |
| 200-Day Moving Average | 0.27 |
| Relative Strength Index (RSI) | 41.56 |
| Average Volume (20 Days) | 5,625,738 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, NOVONIX had revenue of AUD 8.12 million and -140.54 million in losses. Loss per share was -0.18.
| Revenue | 8.12M |
| Gross Profit | 4.51M |
| Operating Income | -75.17M |
| Pretax Income | -142.85M |
| Net Income | -140.54M |
| EBITDA | -68.60M |
| EBIT | -75.17M |
| Loss Per Share | -0.18 |
Balance Sheet
The company has 86.06 million in cash and 132.00 million in debt, with a net cash position of -45.94 million or -0.05 per share.
| Cash & Cash Equivalents | 86.06M |
| Total Debt | 132.00M |
| Net Cash | -45.94M |
| Net Cash Per Share | -0.05 |
| Equity (Book Value) | 227.43M |
| Book Value Per Share | 0.23 |
| Working Capital | -3.66M |
Cash Flow
In the last 12 months, operating cash flow was -62.15 million and capital expenditures -50.81 million, giving a free cash flow of -112.96 million.
| Operating Cash Flow | -62.15M |
| Capital Expenditures | -50.81M |
| Depreciation & Amortization | 6.41M |
| Net Borrowing | 131.58M |
| Free Cash Flow | -112.96M |
| FCF Per Share | -0.11 |
Margins
| Gross Margin | 55.49% |
| Operating Margin | -925.82% |
| Pretax Margin | -1,759.29% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
NOVONIX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -41.30% |
| Shareholder Yield | -41.30% |
| Earnings Yield | -128.07% |
| FCF Yield | -102.94% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
NOVONIX has an Altman Z-Score of -1.44 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -1.44 |
| Piotroski F-Score | 4 |